TrialBritish journal of cancer2002

A double-blind placebo-controlled, randomised study comparing gemcitabine and marimastat with gemcitabine and placebo as first line therapy in patients with advanced pancreatic cancer.

S R Bramhall et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.